Reduction of ∆2-Isoxazolines to ꢀ-Hydroxy
Ketones with Iron and Ammonium Chloride as
Reducing Agent
SCHEME 1. Reductive N-O Bond Cleavage of
∆2-Isoxazolines
Dahong Jiang†,‡ and Yuanwei Chen*,†
Chengdu Institute of Organic Chemistry, Chinese Academy
of Sciences, Chengdu 610041, P. R. China, and
Graduate School of Chinese Academy of Sciences,
Beijing 100049, P. R. China
Notwithstanding these antecedents, it still seems highly desirable
to develop a simple, economical, and general protocol as an
extension of this method for the reduction of both 3-vinyl and
saturated ∆2-isoxazolines to the corresponding ꢀ-hydroxy
ketones.
ReceiVed August 21, 2008
In general, reductive ring opening of ∆2-isoxazolines can
result in either complete reduction to an amino alcohol or N-O
bond reduction/hydrolysis to ꢀ-hydroxy ketones (Scheme 1)
through hydroxyimine intermediates.2b We envisioned that a
judicious choice of reducing agent other than the reported
catalytic hydrogenolysis2b,c and transition metal induced
reduction2f,g,5 might also effect these transformations.
We have recently established a new method for the prepara-
tion of ∆2-isoxazolines via Pd-catalyzed carboetherification of
ꢀ,γ-unsaturated oximes [eq. 1].6 During the course of our
investigation of their N-O bond cleavage, we found that Fe/
NH4Cl can easily reduce the ∆2-isoxazolines to the correspond-
ing ꢀ-hydroxy ketones in the presence of water. Herein, we
would like to report the details of this facile and economical
procedure that has resulted in a new general method for the
chemoselective reduction of ∆2-isoxazolines to ꢀ-hydroxy
ketones.
A detailed study of a procedure for the selective reduction
of ∆2-isoxazolines to the corresponding ꢀ-hydroxy ketones
is reported. The use of iron and ammonium chloride as the
reducing agent in the presence of water results in a facile
and chemoselective protocol for the preparation of ꢀ-hydroxy
ketones, including the conjugated ꢀ-hydroxy ketones.
ꢀ-Hydroxy ketones have been well demonstrated as important
building blocks for the preparation of pharmaceuticals and
natural products,1 and their synthesis has attracted the interest
of many organic chemists. During recent decades, the conversion
of ∆2-isoxazolines to ꢀ-hydroxy ketone derivatives has devel-
oped into a powerful alternative to traditional carbonyl con-
densation methods for the stereoselective synthesis of aldol
adducts.2 However, the sensitivity of other functionalities to the
catalytic hydrogenolysis employed for the isoxazoline ring
opening remains a challenge.3,4 To avoid concomitant reduction
of a conjugated olefin, E. Carreira and J. Bode described a
selective method for the reduction of conjugated ∆2-isoxazolines
to the corresponding unsaturated ꢀ-hydroxy ketones.5
Aiming to develop an easier and less expensive method for
the cleavage of N-O bond in ∆2-isoxazolines, we became
interested in investigating whether the easily available reducing
agents that are effective in the reductive ring openings of
isoxazolidines7 and ∆4-isoxazolines8 would be applied in this
case. Our initial screening with these methods proved unsuc-
cessful in providing the desired γ-amino alcohol 3 or ꢀ-hydroxy
ketone 2a, so we began to investigate Fe/NH4Cl in the presence
of water as an alternative (Table 1).
* To whom correspondence should be addressed.
† Chengdu Institute of Organic Chemistry.
‡ Graduate School of Chinese Academy of Sciences.
At first, substrate 1a was subjected to a suspension of Fe
powder (5 equiv) and NH4Cl (5 equiv) in EtOH/H2O (1:1)
at 60 °C. It was found that only ꢀ-hydroxy ketones 2a along
with the unconsumed starting material were obtained after
5 h (entry 7, Table 1). No products from retroaldol reaction
(1) (a) McGarvey, G. J.; Mathys, J. A.; Wilson, K. J. J. Org. Chem. 1996,
61, 5704. (b) Bartoli, G.; Bosco, M.; Marcantoni, E.; Massaccesi, M.; Rinaldi,
S.; Sambri, L. Eur. J. Org. Chem. 2001, 4679. (c) Sinha, S. C.; Barbas, C. F.;
Lerner, R. A. Proc. Natl. Acad. Sci. USA. 1998, 95, 14603. (d) Paterson, I.;
Florence, G. J.; Gerlach, K.; Scott, J. P.; Sereinig, N. J. Am. Chem. Soc. 2001,
123, 9535. (e) Colle, S.; Taillefumier, C.; Chapleur, Y.; Liebl, R.; Schmidt, A.
Bioorg. Med. Chem. 1999, 7, 1049. (f) Muri, D.; Lohse-Fraefel, N.; Carreira,
E. M. Angew. Chem., Int. Ed. 2005, 44, 4036.
(2) (a) Torsell, K.; Zenthen, O. Acta Chem. Scand. Ser. B 1978, 32, 118. (b)
Curran, D. P. J. Am. Chem. Soc. 1982, 104, 4024. (c) Curran, D. P. J. Am.
Chem. Soc. 1983, 105, 5826. (d) Kozikowski, A. P.; Stein, P. D. J. Am. Chem.
Soc. 1982, 104, 4023. (e) Curran, D. P.; Scanga, S. A.; Fenk, C. J. J. Org. Chem.
1984, 49, 3474. (f) Baraldi, P.; Barco, A.; Benetti, S.; Manfredini, S.; Simoni,
D. Synthesis 1987, 276. (g) Guarna, A.; Guidi, A.; Goti, A.; Brandi, A.; de Sarlo,
F. Synthesis 1989, 175. (h) Kwiatkowshi, S. J. Chem. Soc., Chem. Commun.
1987, 1496.
(5) (a) Bode, J. W.; Carreira, E. M. Org. Lett. 2001, 3, 1587. (b) Bode, J. W.;
Carreira, E. M. J. Am. Chem. Soc. 2001, 123, 3611.
(6) Jiang, D.; Peng, J.; Chen, Y. Org. Lett. 2008, 10, 1695.
(7) (a) Boruah, M.; Konwar, D. J. Chem. Res. 2002, 601. (b) LeBel, N. A.;
Balasubramanian, N. J. Am. Chem. Soc. 1989, 111, 3363. (c) Iida, H.; Kasahara,
K.; Kibayashi, C. J. Am. Chem. Soc. 1986, 108, 4647. (d) Wovkulich, P. M.;
Uskokovic, M. R. Tetrahedron 1985, 41, 3455. (e) Jaeger, V.; Grund, H.; Buss,
V.; Schwab, W.; Mueller, I. Bull. Chem. Soc. Belg. 1983, 92, 1039.
(8) (a) Aschwanden, P.; Kvarno, L.; Geisser, R. W.; Kleinbeck, F.; Carreira,
E. M. Org. Lett. 2005, 7, 5741. (b) Freeman, J. P. Chem. ReV. 1983, 83, 241.
(3) Yadav, P. P.; Ahmad, G.; Maurya, R. Tetrahedron Lett. 2005, 46, 5621.
(4) Kozikowski, A. P. Acc. Chem. Res. 1984, 17, 410.
10.1021/jo801831c CCC: $40.75
Published on Web 10/22/2008
2008 American Chemical Society
J. Org. Chem. 2008, 73, 9181–9183 9181